Patents by Inventor Rodney S. Kenley
Rodney S. Kenley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230364315Abstract: A fluid filtration system comprising a cross-flow filter is arranged to permit a first pump to recirculate part of the retentate of the filter to the inlet of the cross-flow filter and a second pump to return part of the permeate to the inlet of the cross-flow filter. A third pump is configured supply source fluid to the inlet of the filter. The flow path between the second pump and the cross-flow filter inlet may include an adsorption filter that may selectively remove contaminants, toxins, or pathogens in the permeate. A controller may control the first, second and third pumps to provide predetermined flow ratios among the fluid flow paths of the system in order to achieve a desired filtration level. This system may be applicable to the removal of harmful substances from blood, by first separating the plasma from the blood and then removing harmful substances from the plasma.Type: ApplicationFiled: May 30, 2023Publication date: November 16, 2023Inventors: Rodney S. Kenley, Ryan K. LaRocque, Andrew A. Schnellinger
-
Patent number: 11660381Abstract: A fluid filtration system comprising a cross-flow filter is arranged to permit a first pump to recirculate part of the retentate of the filter to the inlet of the cross-flow filter and a second pump to return part of the permeate to the inlet of the cross-flow filter. A third pump is configured supply source fluid to the inlet of the filter. The flow path between the second pump and the cross-flow filter inlet may include an adsorption filter that may selectively remove contaminants, toxins, or pathogens in the permeate. A controller may control the first, second and third pumps to provide predetermined flow ratios among the fluid flow paths of the system in order to achieve a desired filtration level. This system may be applicable to the removal of harmful substances from blood, by first separating the plasma from the blood and then removing harmful substances from the plasma.Type: GrantFiled: March 27, 2020Date of Patent: May 30, 2023Assignee: DEKA Products Limited PartnershipInventors: Rodney S. Kenley, Ryan K. LaRocque, Andrew A. Schnellinger
-
Publication number: 20200222616Abstract: A fluid filtration system comprising a cross-flow filter is arranged to permit a first pump to recirculate part of the retentate of the filter to the inlet of the cross-flow filter and a second pump to return part of the permeate to the inlet of the cross-flow filter. A third pump is configured supply source fluid to the inlet of the filter. The flow path between the second pump and the cross-flow filter inlet may include an adsorption filter that may selectively remove contaminants, toxins, or pathogens in the permeate. A controller may control the first, second and third pumps to provide predetermined flow ratios among the fluid flow paths of the system in order to achieve a desired filtration level. This system may be applicable to the removal of harmful substances from blood, by first separating the plasma from the blood and then removing harmful substances from the plasma.Type: ApplicationFiled: March 27, 2020Publication date: July 16, 2020Inventors: Rodney S. Kenley, Ryan K. LaRocque, Andrew A. Schnellinger
-
Patent number: 10603425Abstract: A fluid filtration system comprising a cross-flow filter is arranged to permit a first pump to recirculate part of the retentate of the filter to the inlet of the cross-flow filter and a second pump to return part of the permeate to the inlet of the cross-flow filter. A third pump is configured supply source fluid to the inlet of the filter. The flow path between the second pump and the cross-flow filter inlet may include an adsorption filter that may selectively remove contaminants, toxins, or pathogens in the permeate. A controller may control the first, second and third pumps to provide predetermined flow ratios among the fluid flow paths of the system in order to achieve a desired filtration level. This system may be applicable to the removal of harmful substances from blood, by first separating the plasma from the blood and then removing harmful substances from the plasma.Type: GrantFiled: May 23, 2016Date of Patent: March 31, 2020Assignee: DEKA Products Limited PartnershipInventors: Rodney S. Kenley, Ryan K. LaRocque, Andrew A. Schnellinger
-
Patent number: 10471186Abstract: Systems and methods for providing for the automatic instrument-based rapid reprocessing of an intact extracorporeal circuit for use in hemodialysis. The system includes a manifold with connectors for engaging a dialyzer as well as venous and arterial blood lines. The manifold is adapted to be moved from a dialysis machine to a reuse instrument without removing the dialyzer and associated blood lines. The system allows for reprocessing of the extracorporeal circuit wherein prior to the next treatment, there is no residual chemical disinfectant requiring testing, the extracorporeal circuit is pre-primed, the levels in the bubble traps are set, and all of the required quality assurance tests are performed and recorded.Type: GrantFiled: April 3, 2017Date of Patent: November 12, 2019Assignees: Baxter International Inc., Baxter Healthcare SAInventor: Rodney S. Kenley
-
METHODS FOR DELIVERING REGIONAL CITRATE ANTICOAGULATION (RCA) DURING EXTRACORPOREAL BLOOD TREATMENTS
Publication number: 20180050148Abstract: Disclosed are methods, compositions, and devices for improved delivery of regional citrate anticoagulation during extracorporeal blood treatments. Methods comprise quantification of the clearance of calcium and/or citrate using one or more on-line/in-line sensors, establishing a correlation between the differential conductivity between afferent and efferent dialysate and the clearance of calcium and/or citrate. The methods described herein further include quantifying citrate clearance using glucose as a surrogate.Type: ApplicationFiled: April 20, 2016Publication date: February 22, 2018Inventor: Rodney S. Kenley -
Publication number: 20170203014Abstract: Systems and methods for providing for the automatic instrument-based rapid reprocessing of an intact extracorporeal circuit for use in hemodialysis. The system includes a manifold with connectors for engaging a dialyzer as well as venous and arterial blood lines. The manifold is adapted to be moved from a dialysis machine to a reuse instrument without removing the dialyzer and associated blood lines. The system allows for reprocessing of the extracorporeal circuit wherein prior to the next treatment, there is no residual chemical disinfectant requiring testing, the extracorporeal circuit is pre-primed, the levels in the bubble traps are set, and all of the required quality assurance tests are performed and recorded.Type: ApplicationFiled: April 3, 2017Publication date: July 20, 2017Inventor: Rodney S. Kenley
-
Patent number: 9616162Abstract: Systems and methods for providing for the automatic instrument-based rapid reprocessing of an intact extracorporeal circuit for use in hemodialysis. The system includes a manifold with connectors for engaging a dialyzer as well as venous and arterial blood lines. The manifold is adapted to be moved from a dialysis machine to a reuse instrument without removing the dialyzer and associated blood lines. The system allows for reprocessing of the extracorporeal circuit wherein prior to the next treatment, there is no residual chemical disinfectant requiring testing, the extracorporeal circuit is pre-primed, the levels in the bubble traps are set, and all of the required quality assurance tests are performed and recorded.Type: GrantFiled: September 20, 2013Date of Patent: April 11, 2017Assignees: Baxter International Inc., Baxter Healthcare SAInventor: Rodney S. Kenley
-
Publication number: 20160263305Abstract: A fluid filtration system comprising a cross-flow filter is arranged to permit a first pump to recirculate part of the retentate of the filter to the inlet of the cross-flow filter and a second pump to return part of the permeate to the inlet of the cross-flow filter. A third pump is configured supply source fluid to the inlet of the filter. The flow path between the second pump and the cross-flow filter inlet may include an adsorption filter that may selectively remove contaminants, toxins, or pathogens in the permeate. A controller may control the first, second and third pumps to provide predetermined flow ratios among the fluid flow paths of the system in order to achieve a desired filtration level. This system may be applicable to the removal of harmful substances from blood, by first separating the plasma from the blood and then removing harmful substances from the plasma.Type: ApplicationFiled: May 23, 2016Publication date: September 15, 2016Inventors: Rodney S. Kenley, Ryan K. LaRocque, Andrew A. Schnellinger
-
Patent number: 9402987Abstract: A device for occluding a flexible tube comprising a first body frictionally connected to a second body by a spring-loaded clip. A flexible tube having a first end and a second end is secured in a bent position to each body by a plurality of clamps. When the two bodies are separated by a predetermined threshold force acting axially on either the first end or second end of the tube so as to cause the bent section of tubing to straighten, the spring-load clip occludes the tube secured by the second body.Type: GrantFiled: February 9, 2015Date of Patent: August 2, 2016Assignee: DEKA Products Limited PartnershipInventors: Dean Kamen, Rodney S. Kenley, Kevin L. Grant, Larry B. Gray, Jason A. Demers
-
Patent number: 9345826Abstract: A fluid filtration system comprising a cross-flow filter is arranged to permit a first pump to recirculate part of the retentate of the filter to the inlet of the cross-flow filter and a second pump to return part of the permeate to the inlet of the cross-flow filter. A third pump is configured supply source fluid to the inlet of the filter. The flow path between the second pump and the cross-flow filter inlet may include an adsorption filter that may selectively remove contaminants, toxins, or pathogens in the permeate. A controller may control the first, second and third pumps to provide predetermined flow ratios among the fluid flow paths of the system in order to achieve a desired filtration level. This system may be applicable to the removal of harmful substances from blood, by first separating the plasma from the blood and then removing harmful substances from the plasma.Type: GrantFiled: September 14, 2012Date of Patent: May 24, 2016Assignee: DEKA Products Limited PartnershipInventors: Rodney S. Kenley, Ryan K. LaRocque, Andrew A. Schnellinger
-
Publication number: 20150151105Abstract: A device for occluding a flexible tube comprising a first body frictionally connected to a second body by a spring-loaded clip. A flexible tube having a first end and a second end is secured in a bent position to each body by a plurality of clamps. When the two bodies are separated by a predetermined threshold force acting axially on either the first end or second end of the tube so as to cause the bent section of tubing to straighten, the spring-load clip occludes the tube secured by the second body.Type: ApplicationFiled: February 9, 2015Publication date: June 4, 2015Inventors: Dean Kamen, Rodney S. Kenley, Keith D. Violette, Kevin L. Grant, Larry B. Gray, Richard J. Lanigan, Jason A. Demers
-
Patent number: 8950728Abstract: A device and method to constrict or occlude the lumen of a flexible tube may include an occluder under the influence of an elastic force, such as a spring force, that can compress a portion of the wall of the flexible tube. The occluder can be under the influence of the elastic force, but prevented from occluding the tube by a stop. The stop can be connected to a tube gripping feature, so that a pulling force on the tube near the gripping feature can disengage the stop from the occluder, releasing the occluder to compress the tube. In some embodiments, the pulling force applied to the tube causes movement of the gripping feature by taking up slack in a portion of the tube held in the device. In other embodiments, the pulling force applied to the tube causes the tube to stretch elastically near the gripping feature, causing the gripping feature to move, and disengaging the stop from the occluder.Type: GrantFiled: February 26, 2010Date of Patent: February 10, 2015Assignee: DEKA Products Limited PartnershipInventors: Rodney S. Kenley, Dean Kamen, Keith D. Violette, Kevin L. Grant, Larry B. Gray, Richard J. Lanigan, Jason A. Demers
-
Publication number: 20140054220Abstract: Systems and methods for providing for the automatic instrument-based rapid reprocessing of an intact extracorporeal circuit for use in hemodialysis. The system includes a manifold with connectors for engaging a dialyzer as well as venous and arterial blood lines. The manifold is adapted to be moved from a dialysis machine to a reuse instrument without removing the dialyzer and associated blood lines. The system allows for reprocessing of the extracorporeal circuit wherein prior to the next treatment, there is no residual chemical disinfectant requiring testing, the extracorporeal circuit is pre-primed, the levels in the bubble traps are set, and all of the required quality assurance tests are performed and recorded.Type: ApplicationFiled: September 20, 2013Publication date: February 27, 2014Inventor: Rodney S. Kenley
-
Patent number: 8562908Abstract: Systems and methods for providing for the automatic instrument-based rapid reprocessing of an intact extracorporeal circuit for use in hemodialysis. The system includes a manifold with connectors for engaging a dialyzer as well as venous and arterial blood lines. The manifold is adapted to be moved from a dialysis machine to a reuse instrument without removing the dialyzer and associated blood lines. The system allows for reprocessing of the extracorporeal circuit wherein prior to the next treatment, there is no residual chemical disinfectant requiring testing, the extracorporeal circuit is pre-primed, the levels in the bubble traps are set, and all of the required quality assurance tests are performed and recorded.Type: GrantFiled: June 29, 2007Date of Patent: October 22, 2013Assignees: Baxter International Inc., Baxter Healthcare S.A.Inventor: Rodney S Kenley
-
Publication number: 20130248450Abstract: A fluid filtration system comprising a cross-flow filter is arranged to permit a first pump to recirculate part of the retentate of the filter to the inlet of the cross-flow filter and a second pump to return part of the permeate to the inlet of the cross-flow filter. A third pump is configured supply source fluid to the inlet of the filter. The flow path between the second pump and the cross-flow filter inlet may include an adsorption filter that may selectively remove contaminants, toxins, or pathogens in the permeate. A controller may control the first, second and third pumps to provide predetermined flow ratios among the fluid flow paths of the system in order to achieve a desired filtration level. This system may be applicable to the removal of harmful substances from blood, by first separating the plasma from the blood and then removing harmful substances from the plasma.Type: ApplicationFiled: September 14, 2012Publication date: September 26, 2013Applicant: DEKA Products Limited PartnershipInventors: Rodney S. Kenley, Ryan K. LaRocque, Andrew A. Schnellinger
-
Publication number: 20130126430Abstract: A water purification system comprising a cross-flow filter is arranged to permit recirculation of the retentate or reject water from the retentate outlet of the filter to the inlet of the filter. A first pump is configured to pump source water into the feed water path of the filter, and to raise the fluid pressure in the feed water path and recirculation path. A second pump is configured to recirculate water from the retentate outlet of the filter to the inlet of the filter at a flow rate substantially higher than the flow rate of water generated by the first pump. A drain path connected to the recirculation path or feed water path may include a flow restrictor to permit removal of highly concentrated reject water while maintaining a minimum fluid pressure within the recirculation flowpath.Type: ApplicationFiled: September 14, 2012Publication date: May 23, 2013Applicant: DEKA Products Limited PartnershipInventors: Rodney S. Kenley, Ryan K. LaRocque, JR., Andrew A. Schnellinger, Marc A. Nisbet, Paul R. Ambler
-
Publication number: 20100234809Abstract: A device and method to constrict or occlude the lumen of a flexible tube may include an occluder under the influence of an elastic force, such as a spring force, that can compress a portion of the wall of the flexible tube. The occluder can be under the influence of the elastic force, but prevented from occluding the tube by a stop. The stop can be connected to a tube gripping feature, so that a pulling force on the tube near the gripping feature can disengage the stop from the occluder, releasing the occluder to compress the tube. In some embodiments, the pulling force applied to the tube causes movement of the gripping feature by taking up slack in a portion of the tube held in the device. In other embodiments, the pulling force applied to the tube causes the tube to stretch elastically near the gripping feature, causing the gripping feature to move, and disengaging the stop from the occluder.Type: ApplicationFiled: February 26, 2010Publication date: September 16, 2010Applicant: DEKA Products Limited PartnershipInventors: Rodney S. Kenley, Dean Kamen, Keith D. Violette, Kevin L. Grant, Larry B. Gray, Richard J. Lanigan, Jason A. Demers
-
Publication number: 20090004053Abstract: Systems and methods for providing for the automatic instrument-based rapid reprocessing of an intact extracorporeal circuit for use in hemodialysis. The system includes a manifold with connectors for engaging a dialyzer as well as venous and arterial blood lines. The manifold is adapted to be moved from a dialysis machine to a reuse instrument without removing the dialyzer and associated blood lines. The system allows for reprocessing of the extracorporeal circuit wherein prior to the next treatment, there is no residual chemical disinfectant requiring testing, the extracorporeal circuit is pre-primed, the levels in the bubble traps are set, and all of the required quality assurance tests are performed and recorded.Type: ApplicationFiled: June 29, 2007Publication date: January 1, 2009Inventor: Rodney S. Kenley
-
Patent number: 6153102Abstract: A method of disinfection of a dead-ended fluid line in a medical instrument such as a dialysis machine is described. The method comprises introducing a heated fluid into the fluid line, allowing the fluid to remain in the line for an experimentally determined optimal dwell period, removing the fluid from the fluid line, and then repeating the cycle for a time period sufficient to achieve a disinfection of the fluid line. The optimum dwell period and frequency for exchanging the heated fluid is determined so that the heated fluid is left resident in the line to exert a cidal effect but not so long that the it cools to the point of being ineffective, nor changed so frequently that that the time spent with no hot water resident in the line begins to detract (e.g., unduly prolong) the disinfection process.Type: GrantFiled: January 25, 1999Date of Patent: November 28, 2000Assignee: Aksys, Ltd.Inventors: Rodney S. Kenley, Derek Wiebenson